{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:56:51Z","timestamp":1789880211215,"version":"4.0.1"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"29","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,29]]},"DOI":"10.18632\/oncotarget.5777","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T17:43:03Z","timestamp":1443548583000},"page":"26716-26728","source":"Crossref","is-referenced-by-count":56,"title":["Serotonin 6 receptor controls alzheimer\u2019s disease and depression"],"prefix":"10.18632","volume":"6","author":[{"given":"Hyung-Mun","family":"Yun","sequence":"first","affiliation":[{"name":"Department of Maxillofacial Tissue Regeneration, School of Dentistry and Research Center for Tooth and Periodontal Regeneration (MRC), Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ran","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Oral & Maxillofacial Regeneration, Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Cheol","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Tissue Regeneration, School of Dentistry and Research Center for Tooth and Periodontal Regeneration (MRC), Kyung Hee University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Stanley Brain Research Laboratory, Stanley Medical Research Institute, Rockville, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Tae","family":"Hong","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Medical Research Center, Chungbuk National University, Chungbuk, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0893-133X(97)00194-2","article-title":"Serotonin in aging, late-life depression, and Alzheimer\u2019s disease: the emerging role of functional imaging","volume":"18","author":"Reynolds","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"2","doi-asserted-by":"crossref","first-page":"M22","DOI":"10.1093\/geronj\/44.1.M22","article-title":"Depression among institutionalized aged: assessment and prevalence estimation","volume":"44","author":"Lawton","year":"1989","journal-title":"J Gerontol"},{"key":"3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.60.5.753","article-title":"Depression as a risk factor for Alzheimer disease: the MIRAGE Study","volume":"60","author":"Farrer","year":"2003","journal-title":"Arch Neurol"},{"key":"4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Loewenstein","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","article-title":"Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression","volume":"63","author":"Haroutunian","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JGP.0b013e31816029ec","article-title":"Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression","volume":"16","author":"Sano","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1471-4159.1996.66010047.x","article-title":"Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor","volume":"66","author":"Hamblin","year":"1996","journal-title":"J Neurochem"},{"key":"8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1568007043482561","article-title":"5-ht6 receptors","volume":"3","author":"Fone","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Sibley","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1074\/jbc.M109.068759","article-title":"Physical interaction of Jab1 with human serotonin 6 G-protein-coupled receptor and their possible roles in cell survival","volume":"285","author":"Rhim","year":"2010","journal-title":"J Biol Chem"},{"key":"11","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M606215200","article-title":"The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn","volume":"282","author":"Rhim","year":"2007","journal-title":"J Biol Chem"},{"key":"12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.npp.1300330","article-title":"Differential involvement of 5-HT(1B\/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer\u2019s disease","volume":"29","author":"Ramirez","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer\u2019s disease","volume":"5","author":"Virley","year":"2008","journal-title":"Neurotherapeutics"},{"key":"14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.npp.1300332","article-title":"The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats","volume":"29","author":"Regan","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuropharm.2007.01.007","article-title":"Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression","volume":"52","author":"Nikiforuk","year":"2007","journal-title":"Neuropharmacology"},{"key":"16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/FBP.0b013e3282d28f9c","article-title":"Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats","volume":"18","author":"Stachowicz","year":"2007","journal-title":"Behav Pharmacol"},{"key":"17","doi-asserted-by":"crossref","first-page":"35763","DOI":"10.1074\/jbc.M801353200","article-title":"X11 proteins regulate the translocation of amyloid beta-protein precursor (APP) into detergent-resistant membrane and suppress the amyloidogenic cleavage of APP by beta-site-cleaving enzyme in brain","volume":"283","author":"Suzuki","year":"2008","journal-title":"J Biol Chem"},{"key":"18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12415","article-title":"Integrative genomics identifies APOE epsilon4 effectors in Alzheimer\u2019s disease","volume":"500","author":"Abeliovich","year":"2013","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tins.2006.03.001","article-title":"The X11 proteins, Abeta production and Alzheimer\u2019s disease","volume":"29","author":"Rogelj","year":"2006","journal-title":"Trends Neurosci"},{"key":"20","doi-asserted-by":"crossref","first-page":"e958","DOI":"10.1038\/cddis.2013.490","article-title":"Placenta-derived mesenchymal stem cells improve memory dysfunction in an Abeta1-42-infused mouse model of Alzheimer\u2019s disease","volume":"4","author":"Hong","year":"2013","journal-title":"Cell Death Dis"},{"key":"21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s12035-013-8479-6","article-title":"Acceleration of the development of Alzheimer\u2019s disease in amyloid beta-infused peroxiredoxin 6 overexpression transgenic mice","volume":"48","author":"Hong","year":"2013","journal-title":"Mol Neurobiol"},{"key":"22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.npp.1301503","article-title":"Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466","volume":"33","author":"Beyer","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0959-4388(97)80013-X","article-title":"Serotonin receptors in cognitive behaviors","volume":"7","author":"Buhot","year":"1997","journal-title":"Curr Opin Neurobiol"},{"key":"24","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.3110-06.2007","article-title":"Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation","volume":"27","author":"Greengard","year":"2007","journal-title":"J Neurosci"},{"key":"25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2990.2000.00254.x","article-title":"Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer\u2019s disease prospectively assessed for behavioural changes","volume":"26","author":"Esiri","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1176\/appi.ajp.161.6.1096","article-title":"Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer\u2019s disease with and without depression","volume":"161","author":"O\u2019Brien","year":"2004","journal-title":"Am J Psychiatry"},{"key":"27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.mp.4001992","article-title":"Molecular studies of major depressive disorder: the epigenetic perspective","volume":"12","author":"Petronis","year":"2007","journal-title":"Mol Psychiatry"},{"key":"28","first-page":"429","article-title":"Characterization of serotonin neurotransmission in knockout mice: implications for major depression","volume":"23","author":"Gobbi","year":"2012","journal-title":"Rev Neurosci"},{"key":"29","doi-asserted-by":"crossref","first-page":"37853","DOI":"10.1074\/jbc.M609312200","article-title":"Enhanced amyloidogenic metabolism of the amyloid beta-protein precursor in the X11L-deficient mouse brain","volume":"281","author":"Suzuki","year":"2006","journal-title":"J Biol Chem"},{"key":"30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-5-35","article-title":"Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain","volume":"5","author":"Suzuki","year":"2010","journal-title":"Mol Neurodegener"},{"key":"31","doi-asserted-by":"crossref","first-page":"49099","DOI":"10.1074\/jbc.M405602200","article-title":"The neuronal adaptor protein X11beta reduces amyloid beta-protein levels and amyloid plaque formation in the brains of transgenic mice","volume":"279","author":"Miller","year":"2004","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"crossref","first-page":"47025","DOI":"10.1074\/jbc.M300503200","article-title":"The neuronal adaptor protein X11alpha reduces Abeta levels in the brains of Alzheimer\u2019s APPswe Tg2576 transgenic mice","volume":"278","author":"Miller","year":"2003","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainresrev.2007.02.009","article-title":"From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission","volume":"55","author":"Belluardo","year":"2007","journal-title":"Brain Res Rev"},{"key":"34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0079-6123(08)00912-6","article-title":"The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer\u2019s disease","volume":"172","author":"Steinbusch","year":"2008","journal-title":"Prog Brain Res"},{"key":"35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jchemneu.2003.10.002","article-title":"The human raphe nuclei and the serotonergic system","volume":"26","author":"Hornung","year":"2003","journal-title":"J Chem Neuroanat"},{"key":"36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0361-9230(92)90169-X","article-title":"GABAergic innervation of serotonergic neurons in the dorsal raphe nucleus of the rat studied by electron microscopy double immunostaining","volume":"29","author":"Nakai","year":"1992","journal-title":"Brain Res Bull"},{"key":"37","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1523\/JNEUROSCI.20-11-04217.2000","article-title":"Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons","volume":"20","author":"Luppi","year":"2000","journal-title":"J Neurosci"},{"key":"38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-3565(24)37608-6","article-title":"Alteration in regulation of serotonin release in rat dorsal raphe nucleus after prolonged exposure to morphine","volume":"286","author":"Auerbach","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(87)90533-4","article-title":"Pertussis toxin blocks 5-HT1A and GABAB receptor-mediated inhibition of serotonergic neurons","volume":"143","author":"Aghajanian","year":"1987","journal-title":"Eur J Pharmacol"},{"key":"40","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1124\/jpet.102.038133","article-title":"GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system","volume":"303","author":"Auerbach","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"41","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1038\/onc.2013.363","article-title":"Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion","volume":"33","author":"Segall","year":"2014","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/elps.201100139","article-title":"Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease","volume":"32","author":"Cifuentes","year":"2011","journal-title":"Electrophoresis"},{"key":"43","doi-asserted-by":"crossref","first-page":"e3029","DOI":"10.1371\/journal.pone.0003029","article-title":"GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP\/PS1 mice and its pharmacological treatment by picrotoxin","volume":"3","author":"Takashima","year":"2008","journal-title":"PLoS One"},{"key":"44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer\u2019s disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis: an update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Higgins","year":"1992","journal-title":"Science"},{"key":"47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/156720506777632835","article-title":"RNA therapeutics directed to the non coding regions of APP mRNA,anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine","volume":"3","author":"Rogers","year":"2006","journal-title":"Curr Alzheimer Res"},{"key":"48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.expneurol.2007.01.037","article-title":"Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice","volume":"205","author":"Mattson","year":"2007","journal-title":"Exp Neurol"},{"key":"49","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans","volume":"108","author":"Sheline","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"50","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1097\/00001756-200011090-00041","article-title":"Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein","volume":"11","author":"Miller","year":"2000","journal-title":"Neuroreport"},{"key":"51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1471-4159.2003.02234.x","article-title":"X11alpha impairs gamma- but not beta-cleavage of amyloid precursor protein","volume":"88","author":"Turner","year":"2004","journal-title":"J Neurochem"},{"key":"52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/mcne.2000.0898","article-title":"X11 alpha and x11 beta interact with presenilin-1their PDZ domains","volume":"16","author":"Miller","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"53","doi-asserted-by":"crossref","first-page":"24277","DOI":"10.1074\/jbc.M211992200","article-title":"Partial purification and characterization of gamma-secretase from post-mortem human brain","volume":"278","author":"Naslund","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T21:19:51Z","timestamp":1748639991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":53,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2015,9,29]]}},"alternative-id":["5777","26449188"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5777","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}